I agree that this site is using cookies. You can find further informations here.
X
Lang, Ninian
182  results:
Search for persons X
?
1

#2246 Cardiovascular changes and outcomes across the early ..:

Stoumpos, Sokratis ; Gillon, Jodie ; Lang, Ninian...
Nephrology Dialysis Transplantation.  39 (2024)  Supplement_1 - p. , 2024
Link: https://doi.org/10.1093/..
 
?
2

#970 The impact of VEGF signalling pathway inhibitors and/o..:

Elyan, Benjamin ; Hedley, James ; Sullivan, Michael...
Nephrology Dialysis Transplantation.  39 (2024)  Supplement_1 - p. , 2024
Link: https://doi.org/10.1093/..
 
?
3

#3880 REDUCED EGFR IS ASSOCIATED WITH IMPROVED SURVIVAL IN ..:

Elyan, Benjamin ; Jones, Rob ; Lang, Ninian..
Nephrology Dialysis Transplantation.  38 (2023)  Supplement_1 - p. , 2023
Link: https://doi.org/10.1093/..
 
?
4

Runx1 deficiency protects against heart failure with preser..:

Elbassioni, Ali Ali ; MacDonald, Eilidh ; Bradley, Ashley...
Journal of Molecular and Cellular Cardiology.  173 (2022)  - p. S12 , 2022
Link: https://doi.org/10.1016/..
 
?
5

Quantitative myocardial inflammation assessed using a novel..:

Semple, Scott ; Alam, Shirjel R ; MacGillivray, Tom J...
Journal of Cardiovascular Magnetic Resonance.  15 (2013)  - p. O114 , 2013
Link: https://doi.org/10.1186/..
 
?
6

NO effect produced by UVA irradiation of skin is independen..:

Liu, Donald ; Lang, Ninian ; Fernandez, Bernadette...
Nitric Oxide.  27 (2012)  - p. S31 , 2012
Link: https://doi.org/10.1016/..
 
?
7

Current drug therapies used in the secondary prevention of ..:

Lang, Ninian ; Fox, Keith
Prescriber.  21 (2010)  19 - p. 22-45 , 2010
Link: https://doi.org/10.1002/..
 
?
8

Current drug therapies for the secondary prevention of MI:

Lang, Ninian ; Fox, Keith
Prescriber.  19 (2008)  1 - p. 14-25 , 2008
Link: https://doi.org/10.1002/..
 
?
9

Intravenous iron and SGLT2 inhibitors in iron‐deficient pat..:

Docherty, Kieran F. ; McMurray, John J.V. ; Kalra, Paul R....
ESC Heart Failure.  , 2024
Link: https://doi.org/10.1002/..
 
?
10

Cardiovascular Eligibility Criteria and Adverse Event Repor..:

Rankin, Stephen ; Elyan, Benjamin ; Jones, Robert...
JACC: CardioOncology.  6 (2024)  2 - p. 267-279 , 2024
Link: https://doi.org/10.1016/..
 
?
11

Empagliflozin to prevent progressive adverse remodelling af..:

Carberry, Jaclyn ; Petrie, Mark C. ; Lee, Matthew M.Y....
ESC Heart Failure.  , 2024
Link: https://doi.org/10.1002/..
 
?
12

Measuring congestion with a non‐invasive monitoring device ..:

Curtain, James P. ; Talebi, Atefeh ; McIntosh, Alasdair...
European Journal of Heart Failure.  26 (2024)  6 - p. 1383-1392 , 2024
Link: https://doi.org/10.1002/..
 
?
13

Socioeconomic deprivation and illness trajectory in the Sco..:

Morrow, Andrew J. ; Sykes, Robert ; Saleh, Merna...
Communications Medicine.  4 (2024)  1 - p. , 2024
Link: https://doi.org/10.1038/..
 
?
14

Reply:

Glen, Claire ; Adam, Sarah ; Coats, Caroline J..
JACC: CardioOncology.  5 (2023)  6 - p. 850 , 2023
Link: https://doi.org/10.1016/..
 
?
15

Characteristics and outcomes of patients with a history of ..:

Dobbin, Stephen J.H. ; Shen, Li ; Petrie, Mark C....
European Journal of Heart Failure.  25 (2023)  4 - p. 488-496 , 2023
Link: https://doi.org/10.1002/..
 
1-15